Stock Performance and Market Context
On 20 Jan 2026, Mukka Proteins Ltd's share price touched Rs.21.75, its lowest level in the past year and an all-time low. This decline comes after four consecutive days of losses, during which the stock has fallen by approximately 1.89%. The stock's performance today was in line with the broader FMCG sector, which has also faced pressure in recent sessions.
The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, signalling a sustained downtrend. This technical positioning reflects persistent weakness in investor sentiment towards the company’s shares.
In contrast, the benchmark Sensex opened flat but later declined by 324.93 points, or 0.44%, closing at 82,882.45. Despite this fall, the Sensex remains only 3.95% below its 52-week high of 86,159.02. However, the index has experienced a three-week consecutive decline, losing 3.36% over this period. The Sensex is trading below its 50-day moving average, though the 50DMA remains above the 200DMA, indicating mixed signals for the broader market.
Long-Term Underperformance
Over the past year, Mukka Proteins Ltd has delivered a negative return of 41.91%, significantly underperforming the Sensex, which posted a positive return of 7.54% during the same period. The stock’s 52-week high was Rs.41.08, highlighting the steep decline to its current level.
This underperformance extends beyond the last year, with the stock lagging behind the BSE500 index over the last three years, one year, and three months. Such sustained underperformance points to structural issues affecting the company’s market valuation and investor confidence.
Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!
- - Rigorous evaluation cleared
- - Expert-backed selection
- - Mid Cap conviction pick
Financial Metrics and Profitability Concerns
Mukka Proteins Ltd’s financial indicators reveal challenges in profitability and debt servicing capacity. The company’s average Return on Capital Employed (ROCE) stands at 9.16%, a figure considered low for the FMCG sector, indicating limited efficiency in generating profits from its capital base.
Debt metrics further highlight concerns, with a Debt to EBITDA ratio of 5.26 times, signalling a relatively high debt burden compared to earnings before interest, tax, depreciation, and amortisation. This elevated leverage ratio suggests constraints on the company’s ability to comfortably service its debt obligations.
Net sales growth has been modest, with an annualised rate of 8.60% over the past five years, reflecting subdued expansion in revenue streams. Additionally, the company has reported negative results for seven consecutive quarters, underscoring persistent profitability pressures.
Quarterly financials show a Profit Before Tax excluding Other Income (PBT less OI) of Rs.3.28 crores, down 67.9% compared to the previous four-quarter average. Net Profit After Tax (PAT) for the quarter was Rs.5.88 crores, a decline of 45.9% relative to the prior four-quarter average. Interest expenses have reached a peak of Rs.12.82 crores, further impacting net profitability.
Institutional Investor Activity
Institutional investors have reduced their holdings by 0.6% in the previous quarter, now collectively holding 3.36% of the company’s shares. This decline in institutional participation may reflect a reassessment of the company’s fundamentals by investors with greater analytical resources and market insight.
Valuation and Growth Considerations
Despite the challenges, Mukka Proteins Ltd exhibits some positive attributes. Operating profit has grown at an annual rate of 50.86%, indicating pockets of operational improvement. The company’s ROCE of 9.2% aligns with a very attractive valuation, supported by an Enterprise Value to Capital Employed ratio of 1.2, suggesting the stock is trading at a discount relative to its peers’ historical valuations.
However, this valuation discount accompanies a 34% decline in profits over the past year, reflecting the broader earnings pressure faced by the company. The juxtaposition of discounted valuation and falling profits illustrates the complex dynamics influencing the stock’s current price level.
Holding Mukka Proteins Ltd from FMCG? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Summary of Key Performance Indicators
Mukka Proteins Ltd’s Mojo Score currently stands at 31.0, with a Mojo Grade of Sell, upgraded from a previous Strong Sell rating on 14 Nov 2025. The company’s market capitalisation grade is 4, reflecting its mid-cap status within the FMCG sector.
The stock’s day change was negative at -0.64%, consistent with the ongoing downward trend. The combination of low profitability, high leverage, declining institutional interest, and sustained negative quarterly results has contributed to the stock’s fall to its 52-week low.
While the broader market has experienced some volatility, Mukka Proteins Ltd’s underperformance relative to the Sensex and sector peers highlights company-specific factors influencing its share price trajectory.
Conclusion
The recent decline of Mukka Proteins Ltd to Rs.21.75, its 52-week and all-time low, reflects a confluence of financial and market factors. The stock’s sustained trading below all major moving averages, coupled with weak profitability metrics and elevated debt levels, has weighed on investor sentiment. Institutional investors’ reduced stake further underscores the cautious stance towards the company’s shares. Despite some positive signs in operating profit growth and valuation discounts, the overall performance indicators point to a challenging environment for the stock at present.
Unlock special upgrade rates for a limited period. Start Saving Now →
